kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant human ErbB-2/HER2 Protein, Fc Tag, premium grade, 100µg  

Recombinant human ErbB-2/HER2 Protein, Fc Tag, premium grade, 100µg

Recombinant Human Her2 / ErbB2 Protein, AA Thr 23 - Thr 652, expressed from human 293 cells (HEK293), Fc Tag, premium grade

recombinant, human, protein, ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN19, NEU, NGL, TKR1, ERBB-2, MLN-19, TKR-1, Epidermal-growth-factor-Receptor-2

More details


Availability: within 7 days

403,00 €

Human Epidermal growth factor Receptor 2 (HER2) is also called ERBB2, HER-2,HER-2 /neu, NEU, NGL,TKR1 and c-erb B2,and is a protein giving higher aggressiveness in breast cancers. It is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family. HER2 is a cell membrane surface-bound receptor tyrosine kinase and is normally involved in the signal transduction pathways leading to cell growth and differentiation. HER2 is thought to be an orphan receptor, with none of the EGF family of ligands able to activate it. Approximately 30% of breast cancers have an amplification of the HER2 gene or overexpression of its protein product. Overexpression of this receptor in breast cancer is associated with increased disease recurrence and worse prognosis. HER2 appears to play roles in development, cancer, communication at the neuromuscular junction and regulation of cell growth and differentiation .

Recombinant Human Her2, Fc Tag, premium grade(HE2-H5253) is expressed from human 293 cells (HEK293). It contains AA Thr 23 - Thr 652 (Accession # P04626-1).
Predicted N-terminus: Thr 23
It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage. When ready to transition into later clinical phases, we also offer a custom GMP protein service that tailors to your needs. We will work with you to customize and develop a GMP-grade product in accordance with your requests that also meets the requirements for raw and ancillary materials use in cell manufacturing of cell-based therapies.

Molecular Characterization
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 96.0 kDa. The protein migrates as 115-130 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

Less than 0.01 EU per μg by the LAL method.

>95% as determined by SDS-PAGE.

The sterility testing was performed by membrane filtration method.


Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

See Certificate of Analysis for details of reconstitution instruction and specific concentration.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Please refer to product data sheet.

Clinical and Translational Updates

(1) "Salivary gland carcinoma: Towards a more personalised approach"
Rached, Saleh, Casiraghi et al
Cancer Treat Rev (2024) 124, 102697
(2) "An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients"
Fabi, Rossi, Mocini et al
Curr Oncol Rep (2024)
(3) "An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity"
Liu, Liu, Su et al
Cardiovasc Drugs Ther (2024)
Showing 1-3 of 41945 papers.